Gene expression profiling shows that EBV-positive DLBCL NOS, is molecularly distinct from EBV-negative DLBCL in Western developed populations, with NFκB p50, STAT-3 and CD30 more commonly expressed in EBV-positive DLBCLs [496]. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.